MannKind Corp (MNKD)
4.725
+0.14
(+2.94%)
USD |
NASDAQ |
May 20, 15:33
MannKind Cash from Investing (Quarterly): -48.44M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -48.44M |
December 31, 2023 | -7.895M |
September 30, 2023 | -11.55M |
June 30, 2023 | 3.664M |
March 31, 2023 | 13.79M |
December 31, 2022 | 15.01M |
September 30, 2022 | 27.35M |
June 30, 2022 | 2.022M |
March 31, 2022 | -39.51M |
December 31, 2021 | -12.58M |
September 30, 2021 | 4.992M |
June 30, 2021 | -112.53M |
March 31, 2021 | -31.42M |
December 31, 2020 | -4.48M |
September 30, 2020 | -0.004M |
June 30, 2020 | -0.15M |
March 31, 2020 | 19.85M |
December 31, 2019 | -0.202M |
September 30, 2019 | 3.761M |
June 30, 2019 | -1.369M |
March 31, 2019 | -25.03M |
December 31, 2018 | -0.244M |
September 30, 2018 | 0.01M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.024M |
March 31, 2017 | 16.65M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | -1.127M |
December 31, 2015 | -0.312M |
September 30, 2015 | -1.154M |
June 30, 2015 | -4.534M |
March 31, 2015 | -4.203M |
December 31, 2014 | -14.21M |
September 30, 2014 | -0.217M |
June 30, 2014 | -8.258M |
March 31, 2014 | -1.409M |
December 31, 2013 | -6.166M |
September 30, 2013 | -0.23M |
June 30, 2013 | -0.132M |
March 31, 2013 | -1.459M |
December 31, 2012 | -0.061M |
September 30, 2012 | -0.124M |
June 30, 2012 | -0.084M |
March 31, 2012 | -0.291M |
December 31, 2011 | -0.125M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-112.53M
Minimum
Jun 2021
27.35M
Maximum
Sep 2022
-8.984M
Average
-0.176M
Median
Cash from Investing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.00 |
Theriva Biologics Inc | 0.00 |
Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 6.703M |
Cash from Financing (Quarterly) | -3.474M |
Free Cash Flow | 3.103M |
Free Cash Flow Per Share (Quarterly) | 0.0132 |
Free Cash Flow to Equity (Quarterly) | 8.846M |
Free Cash Flow to Firm (Quarterly) | 9.982M |
Free Cash Flow Yield | 0.22% |